These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30831254)

  • 1. An institutional review of flying Hymenoptera venom immunotherapy in patients with cutaneous systemic reactions only.
    Nath P; Coop C
    Ann Allergy Asthma Immunol; 2019 May; 122(5):533-534. PubMed ID: 30831254
    [No Abstract]   [Full Text] [Related]  

  • 2. Hymenoptera venom immunotherapy: Past, present, and future.
    Oppenheimer J; Golden DBK
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):276-277. PubMed ID: 29909053
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of national guidelines on venom immunotherapy practice in the United Kingdom.
    Diwakar L; Ewan P; Huber PA; Clark A; Nasser S; Krishna MT
    Clin Exp Allergy; 2016 May; 46(5):749-53. PubMed ID: 26989871
    [No Abstract]   [Full Text] [Related]  

  • 4. Stinging insect hypersensitivity. Safety and efficacy of venom immunotherapy.
    Golub JR; Kaplan SR; Mascia AV
    N Y State J Med; 1984 Feb; 84(2):66-8. PubMed ID: 6583559
    [No Abstract]   [Full Text] [Related]  

  • 5. Imported fire ant hypersensitivity and mastocytosis: A case series of successful venom immunotherapy.
    Nath P; Adams K; Schapira R; Edwards K
    Ann Allergy Asthma Immunol; 2019 May; 122(5):541-542. PubMed ID: 30831255
    [No Abstract]   [Full Text] [Related]  

  • 6. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
    Stritzke AI; Eng PA
    Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hymenoptera venom immunotherapy.
    Bilò BM; Bonifazi F
    Immunotherapy; 2011 Feb; 3(2):229-46. PubMed ID: 21322761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hymenoptera venom allergy.
    Przybilla B; Ruëff F
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insect venoms.
    Müller UR
    Chem Immunol Allergy; 2010; 95():141-156. PubMed ID: 20519887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
    Fricker M; Helbling A; Schwartz L; Müller U
    J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stinging insect allergy and venom immunotherapy.
    Gupta P; Greenberger PA
    Allergy Asthma Proc; 2004; 25(4 Suppl 1):S9-10. PubMed ID: 15515364
    [No Abstract]   [Full Text] [Related]  

  • 13. Venom extracts available to treat patients at risk from insect stings.
    Gunby P
    JAMA; 1979 May; 241(21):2243-6. PubMed ID: 439282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bee and wasp venom allergy. Clinical aspects, prevention and therapy].
    Ring J; Lonsdorf G; Schury W; Burg G
    MMW Munch Med Wochenschr; 1982 Jun; 124(24):587-90. PubMed ID: 6810134
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
    Bernstein JA; Kagen SL; Bernstein DI; Bernstein IL
    Ann Allergy; 1994 Nov; 73(5):423-8. PubMed ID: 7978535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrarush immunotherapy in patients with Hymenoptera venom allergy.
    Ruëff F; Przybilla B
    J Allergy Clin Immunol; 2001 May; 107(5):928-9. PubMed ID: 11344369
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuous immunotherapy for hymenoptera venom allergy using six month intervals.
    Baenkler HW; Meusser-Storm S; Eger G
    Allergol Immunopathol (Madr); 2005; 33(1):7-14. PubMed ID: 15777517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intolerance of specific immunotherapy with Hymenoptera venom: jumping the hurdle with omalizumab].
    Wieczorek D; Kapp A; Wedi B
    Hautarzt; 2014 Sep; 65(9):791-5. PubMed ID: 25234627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.